Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib-Revisiting the immunomechanisms of the JAK pathway

Sardana, K; Bathula, S; Khurana, A

Sardana, K (通讯作者),Atal Bihari Vajpayee Inst Med Sci & Dr Ram Manohar, New Delhi 110001, India.

INDIAN DERMATOLOGY ONLINE JOURNAL, 2023; 14 (4): 465